DE69229948D1 - hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN - Google Patents
hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSENInfo
- Publication number
- DE69229948D1 DE69229948D1 DE69229948T DE69229948T DE69229948D1 DE 69229948 D1 DE69229948 D1 DE 69229948D1 DE 69229948 T DE69229948 T DE 69229948T DE 69229948 T DE69229948 T DE 69229948T DE 69229948 D1 DE69229948 D1 DE 69229948D1
- Authority
- DE
- Germany
- Prior art keywords
- hgpiib
- fragments
- vivo
- thrombotic events
- vitro procedures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69338891A | 1991-04-30 | 1991-04-30 | |
PCT/US1992/003419 WO1992019760A1 (en) | 1991-04-30 | 1992-04-27 | In vitro methods for determining in vivo thrombotic events |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69229948D1 true DE69229948D1 (de) | 1999-10-14 |
DE69229948T2 DE69229948T2 (de) | 2000-03-16 |
Family
ID=24784451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69229948T Expired - Fee Related DE69229948T2 (de) | 1991-04-30 | 1992-04-27 | hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN |
Country Status (10)
Country | Link |
---|---|
US (5) | US5763580A (de) |
EP (1) | EP0583352B1 (de) |
AT (1) | ATE184286T1 (de) |
AU (1) | AU7407096A (de) |
CA (1) | CA2102115C (de) |
DE (1) | DE69229948T2 (de) |
DK (1) | DK0583352T3 (de) |
ES (1) | ES2136085T3 (de) |
GR (1) | GR3031803T3 (de) |
WO (1) | WO1992019760A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2102115C (en) * | 1991-04-30 | 2009-04-07 | Mark H. Ginsberg | In vitro methods for determining in vivo thrombotic events |
US6046316A (en) * | 1997-12-09 | 2000-04-04 | Wayne State University | Nucleic acid encoding truncated integrins |
US6623981B2 (en) | 1998-01-27 | 2003-09-23 | Bristol-Myers Squibb Company | Detection of patients at risk for developing integrin antagonist/agonist mediated disease states |
CA2331244C (en) * | 2000-01-21 | 2009-06-30 | Anchor Coin, Inc. | Method and apparatus for awarding and redeeming promotional points at an electronic game |
US20050233390A1 (en) * | 2003-04-09 | 2005-10-20 | Allen John W | Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5114842A (en) * | 1987-07-08 | 1992-05-19 | The Scripps Research Institute | Peptides and antibodies that inhibit platelet adhesion |
US5196511A (en) * | 1989-12-01 | 1993-03-23 | The Scripps Research Institute | Peptides and antibodies that inhibit integrin-ligand binding |
US5436163A (en) * | 1989-12-01 | 1995-07-25 | The Blood Center Of Southeastern Wisconsin | Polymorphism of human platelet membrane glycoprotein IIb and diagnostic applications thereof |
CA2102115C (en) * | 1991-04-30 | 2009-04-07 | Mark H. Ginsberg | In vitro methods for determining in vivo thrombotic events |
-
1992
- 1992-04-27 CA CA002102115A patent/CA2102115C/en not_active Expired - Fee Related
- 1992-04-27 AT AT92911047T patent/ATE184286T1/de not_active IP Right Cessation
- 1992-04-27 WO PCT/US1992/003419 patent/WO1992019760A1/en active IP Right Grant
- 1992-04-27 EP EP92911047A patent/EP0583352B1/de not_active Expired - Lifetime
- 1992-04-27 DK DK92911047T patent/DK0583352T3/da active
- 1992-04-27 DE DE69229948T patent/DE69229948T2/de not_active Expired - Fee Related
- 1992-04-27 ES ES92911047T patent/ES2136085T3/es not_active Expired - Lifetime
-
1994
- 1994-01-26 US US08/187,829 patent/US5763580A/en not_active Expired - Fee Related
-
1996
- 1996-11-29 AU AU74070/96A patent/AU7407096A/en not_active Abandoned
-
1998
- 1998-02-10 US US09/021,290 patent/US6063907A/en not_active Expired - Fee Related
-
1999
- 1999-11-10 GR GR990402896T patent/GR3031803T3/el unknown
-
2000
- 2000-05-16 US US09/572,046 patent/US6323324B1/en not_active Expired - Fee Related
-
2001
- 2001-10-04 US US09/972,137 patent/US6787320B2/en not_active Expired - Fee Related
-
2004
- 2004-09-03 US US10/934,774 patent/US7122324B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6323324B1 (en) | 2001-11-27 |
ES2136085T3 (es) | 1999-11-16 |
GR3031803T3 (en) | 2000-02-29 |
AU7407096A (en) | 1997-01-30 |
ATE184286T1 (de) | 1999-09-15 |
DE69229948T2 (de) | 2000-03-16 |
US20050136482A1 (en) | 2005-06-23 |
CA2102115A1 (en) | 1992-10-31 |
AU671419B2 (en) | 1996-08-29 |
EP0583352B1 (de) | 1999-09-08 |
US7122324B2 (en) | 2006-10-17 |
DK0583352T3 (da) | 1999-12-20 |
US20020177173A1 (en) | 2002-11-28 |
US6063907A (en) | 2000-05-16 |
AU1782892A (en) | 1992-12-21 |
US6787320B2 (en) | 2004-09-07 |
EP0583352A4 (de) | 1995-06-14 |
CA2102115C (en) | 2009-04-07 |
WO1992019760A1 (en) | 1992-11-12 |
US5763580A (en) | 1998-06-09 |
EP0583352A1 (de) | 1994-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3029740T3 (en) | Fragments of prion proteins. | |
ATE128183T1 (de) | Peptide und antikörper, die die bindung von blutplättchen verhindern. | |
MX9801687A (es) | Compuestos y metodos para el diagnostico de tuberculosis. | |
WO1998053076A3 (en) | Compounds for diagnosis of tuberculosis and methods for their use | |
WO2000045176A3 (de) | VERFAHREN ZUM NACHWEIS VON N-TERMINALEM proBNP | |
CA2345024A1 (en) | Modified tgf-.beta. superfamily proteins | |
DK0980429T3 (da) | Human Toll-lignende receptorproteiner, beslægtede reagenser og fremgangsmåder | |
WO1998016645A3 (en) | Compounds and methods for diagnosis of tuberculosis | |
DE69534996D1 (de) | Monoklonaler antikörper gegen flt4-rezeptor-tyrosinkinase und dessen verwendung zur diagnose und therapie | |
DE69504959D1 (de) | Humanisierte monoklonale antikörper gegen humanes interleukin - 4 | |
ES2072423T3 (es) | Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre. | |
HK1021229A1 (en) | A in vitro method of determining the presence of aprotein in an isolated biological sample. | |
DE68917273D1 (de) | Testmethode und Gerät zur Bestimmung des gesamten Proteins. | |
DE69229948D1 (de) | hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN | |
NO177463C (no) | STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve | |
ATE173830T1 (de) | Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten | |
EP0563244A4 (en) | Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis | |
ATE153770T1 (de) | Künstliche standard- und kontrollseren zur verwendung in verfahren zur bestimmung von antikörpern | |
WO2001065262A3 (en) | Reagents and methods useful for detecting diseases of the breast | |
EP1712629A3 (de) | Verbindungen und Verfahren zur Diagnose von Tuberkulose | |
SE9601231D0 (sv) | Monoclonal antibody | |
DE69333683D1 (de) | Antikörper-testbesteck zur bestimmung von amylin | |
NO952506L (no) | Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |